Literature DB >> 1375684

Modulation of inotropic therapy by venodilation in acute heart failure: a randomised comparison of four inotropic agents, alone and combined with isosorbide dinitrate.

S P Verma1, B Silke, G W Reynolds, A Richmond, S H Taylor.   

Abstract

The effects of four inotropic agents with differing ancillary properties [a cardiac glycoside (digoxin), a combined alpha- and beta-adrenergic agonist (dobutamine), a beta-adrenergic agonist (prenalterol), and a phosphodiesterase inhibitor (amrinone)] alone and with subsequent addition of isosorbide dinitrate were compared in 48 consecutive acute myocardial infarction patients with radiographic and haemodynamic (pulmonary artery occluded pressure greater than 18 mm Hg) left ventricular failure. All agents with the exception of dobutamine reduced the elevated left heart filling pressure; only digoxin and dobutamine augmented the cardiac stroke volume index. All drugs except digoxin reduced the SVRI; an arteriolar constrictor response was evident 60 min after digoxin and a tachycardia resulted after combined alpha- and beta- and beta-adrenergic stimulations (dobutamine and prenalterol, respectively). The addition of isosorbide dinitrate reversed the inotrope-induced elevations of systemic arterial pressure and resulted in additional reductions in left heart filling pressure. These data suggest that, in the absence of substantial venodilator properties in an inotropic compound, reduction in elevated left heart filling pressure is not achieved with inotropic therapy alone in acute left ventricular failure and combining a venodilator may be haemodynamically advantageous.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1375684     DOI: 10.1097/00005344-199201000-00004

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  1 in total

1.  The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo.

Authors:  Euan A Ashley; Jennifer Powers; Mary Chen; Ramendra Kundu; Tom Finsterbach; Anthony Caffarelli; Alicia Deng; Jens Eichhorn; Raina Mahajan; Rani Agrawal; Joan Greve; Robert Robbins; Andrew J Patterson; Daniel Bernstein; Thomas Quertermous
Journal:  Cardiovasc Res       Date:  2005-01-01       Impact factor: 10.787

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.